119 related articles for article (PubMed ID: 3607821)
1. Evaluation of ethanol as an antiemetic in patients receiving cisplatin.
Spiess JL; Adelstein DJ; Hines JD
Clin Ther; 1987; 9(4):400-4. PubMed ID: 3607821
[TBL] [Abstract][Full Text] [Related]
2. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
Presant CA; Wiseman C; Gala K; Kennedy P; Bouzaglou A; Blayney D; Schindler J; Rigas M; Melville J; Dolan J
Prog Clin Biol Res; 1987; 248():299-302. PubMed ID: 3671417
[No Abstract] [Full Text] [Related]
6. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness.
Parashos PJ; Dugan WM; Fry MW
Prog Clin Biol Res; 1987; 248():303-11. PubMed ID: 3118389
[No Abstract] [Full Text] [Related]
8. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
Tanimura S; Banba J; Tomoyasu H; Masaki M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
[TBL] [Abstract][Full Text] [Related]
11. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
12. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
[TBL] [Abstract][Full Text] [Related]
13. [The control of chemotherapy-induced nausea and vomiting].
Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
[TBL] [Abstract][Full Text] [Related]
14. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
Wilder-Smith C; Schimke J; Vergin H; Senn HJ
Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
[TBL] [Abstract][Full Text] [Related]
15. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
Yoshiya N; Kodama S; Tanaka K; Hataya I; Tokunaga A; Takeuchi Y; Hanaoka J; Yanase T; Takahashi T; Maruhashi T
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1641-6. PubMed ID: 8060140
[TBL] [Abstract][Full Text] [Related]
17. [Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
Dozono H; Ohmi K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):454-7. PubMed ID: 3954370
[TBL] [Abstract][Full Text] [Related]
18. Antiemetics for patients treated with antitumor chemotherapy.
Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
[TBL] [Abstract][Full Text] [Related]
19. [Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
Aasebø U; Myhr K
Tidsskr Nor Laegeforen; 1985 Jan; 105(2):148-9. PubMed ID: 4038825
[No Abstract] [Full Text] [Related]
20. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
